{
  "id": "f71b17dab7420f77",
  "title": "Jim Cramer on Insmed :  This One Is Worth Keeping an Eye On  ",
  "description": "20260108T130000Z",
  "content": "",
  "source": "finance.yahoo.com",
  "source_url": "https://finance.yahoo.com/news/jim-cramer-insmed-one-worth-122020473.html",
  "published_at": "20260108T130000Z",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://finance.yahoo.com/news/jim-cramer-insmed-one-worth-122020473.html",
    "url_mobile": "",
    "title": "Jim Cramer on Insmed :  This One Is Worth Keeping an Eye On  ",
    "seendate": "20260108T130000Z",
    "socialimage": "https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6",
    "domain": "finance.yahoo.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}